Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sumber Global Energy Tbk. (SGER)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sumber Global Energy Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sumber Global Energy Tbk. diperdagangkan di Rp680 (kapitalisasi pasar 11,22 T, volume 24 jam 57,35 jt). Perbedaan utamanya: Sumber Global Energy Tbk. jauh lebih besar — sekitar 107,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SGER | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 11,22 T |
Volume | — | 57,35 jt |
Lot | — | 573,49 rb |
Perputaran | — | 38,8 M |
Harga Rata-rata | — | 676,62 |
Nilai Transaksi | — | 38,8 M |
Harga Ekuilibrium Indikatif | — | 680 |
Volume Ekuilibrium Indikatif | — | 2,87 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sumber Global Energy Tbk.
PT Sumber Global Energy Tbk (the Company) was established based on Notarial Deed No. 7 datedMarch 17, 2008 of Sri Hidianingsih, S.H., a public notary in Jakarta. The Company commenced operations in 2011.
Selengkapnya di halaman SGER →
